Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) represents one of the leading causes of cancer-related mortality across the globe. Mitochondrial energy metabolism pathways play pivotal roles in many congenital diseases, inflammation, and malignancies including CRC. The prognostic genes of mitochondrial energy metabolism-related genes (MMRGs) in CRC patients were explored in the research. Transcriptomic profiles were retrieved from TCGA-COAD, TCGA-READ, and GSE38832 public repositories. Differential expression analysis was then conducted to identify genes with altered expression between tumor and adjacent normal tissues. After the weighted gene co-expression network analysis (WGCNA), the module genes related to CRC were identified. By overlapping differentially expressed genes (DEGs), module genes, and MMRGs, the candidate genes were identified. Based on the least absolute shrinkage and selection operator (LASSO)-Cox regression model, the prognostic genes were selected, and the prognostic risk model was constructed. CRC patients were classified as high- and low-risk groups according to the cut-off value risk score. Subsequently, a nomogram was developed to predict overall survival (OS) outcomes in CRC patients. Additionally, immune cell infiltration patterns and a competitive endogenous RNA (ceRNA) regulatory network were characterized in the TCGA-CRC cohort. Furthermore, clinical CRC specimens were collected and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to experimentally validate prognostic gene expression. The TCGA-CRC cohort, comprising 621 CRC and 51 normal samples, yielded 5,227 DEGs through comparative analysis. After overlapping, a total of 25 candidate genes were identified. Then, four prognostic genes were selected, including SUCLG2 , ABHD5 , MPC1 , and FABP4 . Based on this result, a prognostic risk model was constructed, and ROC curves indicated that the model had a great predictive ability. Afterwards, the nomogram model was established according to age, tumor stage, and risk score in patients with CRC. Moreover, the abundance of resting memory CD4 + T cells in TCGA-CRC was the highest. Within public datasets, four prognostic genes were significantly downregulated in CRC samples, and RT-qPCR confirmed the reliability of these trends. Overall, SUCLG2 , ABHD5 , MPC1 , and FABP4 could be potential therapeutic targets of CRC, which could potentially help in the treatment of CRC.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: